Abstract Background Gallbladder carcinoma (GBC) is an extremely aggressive tumor of the biliary tract with a bleak prognosis. and the evidence supporting the benefit of available systemic therapy for advanced GBC is scarce. Herein. this study intended to investigate the real-world outcome of chemotherapy combined with programmed death-1 (PD-1) inhibitor for the management of unresecta... https://www.spidertattooz.com/